Koers Propanc Health Group Corp Other OTC
Aandelen
US74345C1027
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 559K 519K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -1,86 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,86 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,09 mln. 1,02 mln. | Nettoschuld 2023 | 536K 498K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,07
x | K/w-verhouding 2023 |
-0,08
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 97,69% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 50 | 15-10-07 | |
Julian Kenyon
FOU | Founder | 77 | 15-10-07 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 50 | 15-10-07 | |
Julian Kenyon
FOU | Founder | 77 | 15-10-07 |
Josef Zelinger
BRD | Director/Board Member | 74 | 23-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |
- Beurs
- Aandelen
- Koers PPCB
- Koers